Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 264 (RNA5SP264) is a genomic sequence that closely resembles a functional 5S rRNA gene but is classified as a pseudogene, meaning it has lost its ability to code for a functional product due to sequence mutations or lack of appropriate promoters or regulatory elements[6][2]. Pseudogenes like RNA5SP264 may be transcribed at low levels, but any RNA products are usually nonfunctional and not incorporated into ribosomes. The pseudogene status distinguishes it from authentic 5S rRNA genes, which are structural RNA molecules essential for ribosome assembly and function in protein synthesis[1][3]. As a pseudogene, RNA5SP264 does not play a role in normal molecular biology or disease and is not a therapeutic target[2][6]. It is primarily of interest for genomic annotation and evolutionary studies but should not be confused with functional rRNA genes. Key points: - Not a receptor, enzyme, or drug target. - Pseudogenes are nonfunctional DNA elements that may resemble genes but lack function due to mutation or loss of regulatory elements[6]. - "5S ribosomal pseudogenes" are especially common due to the abundance and repetitive nature of ribosomal RNA gene families[2]. - This pseudogene has no clinical relevance as a therapeutic or diagnostic target. If further molecular annotation or functional roles for this or similar pseudogenes are discovered in the future, updated references should be consulted as genomics annotation is an evolving field.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 264 (RNA5SP264).